Tag: insulin degludec/liraglutide

Insulin Degludec/Liraglutide 1 Step Closer to US FDA Approval

An FDA advisory committee has voted unanimously in favor of approval of the combination type 2 diabetes treatment insulin degludec/liraglutide. The panel also agreed that the combination treatment would at least be appropriate for patients who had previously used an insulin analogue or GLP-1 agonist, but no other consensus was reached regarding which patient types […]